Tonix Pharmaceuticals
Sarah Roth is a qualified professional in quality assurance with experience in the pharmaceutical and retail sectors. Currently serving as a Quality Assurance Associate at Tonix Pharmaceuticals since July 2022, Sarah is responsible for reviewing and approving Standard Operating Procedures, providing quality support in validation processes, and implementing the Veeva QMS system. Prior experience includes serving as a Quality Assurance Specialist at Associates of Cape Cod, Inc., where Sarah managed quality investigations and prepared for customer audits. With a strong educational background, Sarah holds a Master's degree in Biotechnology-Regulatory Affairs and a Master's of Science in Business with a focus on Organizational Development from Bridgewater State University, along with a Bachelor’s degree in Marketing.
This person is not in any offices
Tonix Pharmaceuticals
Tonix is developing innovative pharmaceutical products to address major public health challenges. In addition to Tonmya for PTSD, Tonix is developing TNX-601 (tianeptine oxalate), a clinical candidate at pre-IND (Investigational New Drug) application stage, designed as a daytime treatment for PTSD, and TNX-801, a live synthetic version of horsepox virus, at the pre-IND application stage, to be developed as a potential smallpox-preventing vaccine.